Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
[ Ссылка ]
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
[ Ссылка ]
Get the latest in tech from Silicon Valley and around the world here:
[ Ссылка ]
Connect with us on...
X: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Follow Ed Ludlow on X here: [ Ссылка ]
Follow Caroline Hyde on X here: [ Ссылка ]
Listen to the daily Bloomberg Technology podcast here:
[ Ссылка ]
More from Bloomberg Business
Connect with us on...
X: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
TikTok: [ Ссылка ]
